← Back to Search

Patients with Pancreatic Cancer Ductal Adenocarcinoma (Training) for Pancreatic Cancer (PCDC Trial)

N/A
Recruiting
Led By Ajay Goel, PhD
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
No Placebo-Only Group

Summary

This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.

Eligible Conditions
  • Pancreatic Cancer
  • Pancreatic Adenocarcinoma
  • Pancreatic intraepithelial neoplasia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Sensitivity
Secondary study objectives
Accuracy
Specificity

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Group I: Patients with Pancreatic Cancer Ductal Adenocarcinoma (Validation)Experimental Treatment1 Intervention
Individuals diagnosed with pancreatic ductal adenocarcinoma
Group II: Patients with Pancreatic Cancer Ductal Adenocarcinoma (Training)Experimental Treatment1 Intervention
Individuals diagnosed with pancreatic ductal adenocarcinoma
Group III: Individuals without Pancreatic Cancer Ductal Adenocarcinoma (Validation)Experimental Treatment1 Intervention
Individuals without pancreatic ductal adenocarcinoma
Group IV: Individuals without Pancreatic Cancer Ductal Adenocarcinoma (Training)Experimental Treatment1 Intervention
Individuals without pancreatic ductal adenocarcinoma

Find a Location

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor
598 Previous Clinical Trials
1,921,376 Total Patients Enrolled
Ajay Goel, PhDPrincipal InvestigatorCity of Hope Medical Center
9 Previous Clinical Trials
5,244 Total Patients Enrolled
~750 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top